Skip to main content

Claire Fraser Named the Inaugural Dean’s Endowed Professor

December 09, 2015

Claire Fraser, PhD

Claire Fraser, PhD, was presented with the inaugural Dean’s Endowed Professorship in the School of Medicine on December 7, 2015. The ceremony, which took place in Westminster Hall, also honored Robert E. Fischell, ScD, and his wife Susan R. Fischell for their generous support. The couple funded the professorship but chose not to put it in their names.

Endowed professorships provide faculty with critical resources needed to sustain and expand promising research, launch innovative clinical initiatives, and educate and train future physicians. The University of Maryland School of Medicine has more than 70 endowed chairs and professorships. Faculty members such as Dr. Fraser are crucial to helping the School of Medicine maintain high standards in research and patient care.

“It is because of endowed professorships like this that we can recruit faculty members of great significance to these positions, which continues a tradition going back 500 years,” said E. Albert Reece, MD, PhD, MBA, Vice President for Medical Affairs, University of Maryland, and the John Z. and Akiko K. Bowers Distinguished Professor and Dean of the School of Medicine. “The talented faculty members who hold endowed chairs and professorships inspire our students, advance the frontiers of knowledge, and make discoveries that change people’s lives.”

Dr. Fraser, a Professor of Medicine and Microbiology & Immunology at the University of Maryland School of Medicine (UM SOM), is Director of the Institute for Genome Sciences, which she helped establish at UM SOM in 2007, at the behest of Dean Reece. “I think we’ve delivered on the promise to make the University of Maryland School of Medicine one of the leading institutions in the field of genomics,” Dr. Fraser said.

Dr. Fraser, who was previously the President and Director of The Institute for Genomic Research (TIGR) in Rockville, MD, has played a seminal role in the sequencing and analysis of human, animal, plant and microbial genomes to better understand the role that genes play in development, evolution, physiology and disease. She led the teams that first sequenced the genomes of several microbial organisms, including important human and animal pathogens, and as a consequence helped to initiate the era of comparative genomics. Her current research interests are focused on the structure and function of the human gut microbiota.

Dr. Fraser has more than 240 scientific publications, and has been cited in other scientific papers more than 50,000 times. She has served on committees of the National Science Foundation, Department of Energy and National Institutes of Health. She is the recipient of numerous awards and honors including the Promega Biotechnology Award and the E.O. Lawrence Award from the Department of Energy, she is a Fellow of AAAS and the American Association of Microbiology, and she has been elected into the Maryland Women's Hall of Fame and the National Academy of Medicine.

Dr. Fischell is a physicist, inventor and holder of more than 200 U.S. and foreign patents on medical devices and spacecraft. With the active assistance of his wife Susan, his inventions have led to the creation of several biotechnology companies. These inventions include a rechargeable implantable pacemaker that can be programmed with radio waves (Pacesetter Systems, Inc., now St. Jude Medical), which he and his team later helped miniaturize, to save even more lives; the implantable insulin pump (now a product of Medtronic MiniMed); numerous coronary stents used to open clogged arteries (IsoStent, Inc., which merged with Cordis, a Johnson & Johnson company); and two feedback systems that provide early warning signs of both epileptic seizures (NeuroPace, Inc.) and heart attacks (Angel Medical Systems, Inc.). In 2005, Dr. Fischell was awarded a $100,000 TED prize to pursue his work on the design of a device to cure migraines without medication. That device (eNeura, Inc.) received FDA approval in May 2014. Dr. Fischell also was a co-inventor on a device to treat epilepsy that received FDA approval in November 2013.

“I am honored to be the inaugural recipient of the Dean’s Endowed Professorship,” said Dr. Fraser. “Dr. Fischell, particularly, is inspired by a pioneering spirit, something he has obviously leveraged multiple times, first to usher in the modern era of space satellites in his former career, and now to invent multiple life-saving devices. Perhaps he and I will find a project on which we can collaborate. I would like to think that between the two of us we could bring all the elements of success to the table.”


Office of Public Affairs
655 West Baltimore Street
Bressler Research Building 14-002
Baltimore, Maryland 21201-1559

Contact Media Relations
(410) 706-5260

Related stories

    Thursday, June 23, 2022

    New Research Shows Mothers’ HIV Status, Breastfeeding, and the Infant Gut Microbiome Can Have Long-Term Impact on Infant Health

    Babies born to women with HIV often have poorer health and under-developed growth in the early months of life than infants born to women without the infection — even if those babies don’t contract HIV during birth, according to a new study by researchers at the University of Maryland School of Medicine (UMSOM)’s Institute for Genome Sciences (IGS) and Institute of Human Virology (IHV). The study also provides new insights into why these health issues often continue throughout the babies’ lives.

    Wednesday, September 15, 2021

    Probiotic-Containing Yogurt Protects Against Microbiome Changes That Lead to Antibiotic-Induced Diarrhea, Study Finds

    Eating yogurt containing a particular strain of a well-studied probiotic appears to protect against harmful changes in the gut microbiome that are associated with antibiotic administration. That is the finding from a new randomized clinical trial, led by researchers at the University of Maryland School of Maryland (UMSOM), the University of Maryland School of Pharmacy (UMSOP), and Georgetown University Medical Center, which was recently published in the journal Nutrients.

    Thursday, March 18, 2021

    UM School of Medicine Helps Maryland Conduct State-Wide Sequencing of Variants in Positive COVID-19 Test Specimens

    In an effort to monitor the spread of COVID-19 variants in the State of Maryland, University of Maryland School of Medicine (UMSOM) Dean E. Albert Reece, MD, PhD, MBA, announced that UMaryland Genomics at UMSOM will perform genome sequencing of variants in at least 10 percent of COVID-19 test samples, reaching an important benchmark set by the federal government to help control the spread of these variants.

    Tuesday, February 12, 2019

    UMSOM Scientists Call for Unrestricted Usage of Public Genome Data

    Researchers at the Institute for Genome Sciences (IGS) at the University of Maryland School of Medicine (UMSOM) called for open access to genome data, stating that unrestricted usage is needed for progress in combatting the world’s most serious diseases.

    Tuesday, December 04, 2018

    UMSOM/UMSOP Researchers Awarded $1.78 Million Grant to Study Brain-To-Gut Connection in Schizophrenia

    Researchers at the University of Maryland School of Medicine’s (UMSOM) Maryland Psychiatric Center (MPRC) and Institute for Genome Sciences (IGS), along with researchers at the University of Maryland School of Pharmacy (UMSOP), have been awarded a collaborative five-year $1.78 million grant to study the brain-to-gut connection in schizophrenia.

    Monday, February 08, 2016

    UM SOM Researchers Identify Most Dangerous Strains of Often-Deadly Bacteria

    A multi-disciplinary group of researchers at the University of Maryland School of Medicine (UM SOM) have for the first time determined the genetic makeup of various strains of E. coli, which every year kills hundreds of thousands of people around the world.

    Thursday, January 21, 2016

    UM SOM Board Member and Benefactor Robert E. Fischell, Awarded Presidential Medal

    The White House has awarded Robert E. Fischell, ScD, a member of the University of Maryland School of Medicine (UM SOM) Board of Visitors, the National Medal of Technology and Innovation, the highest honor for technological achievement bestowed by the president of the United States. Previous recipients have included such luminaries as Steven Jobs and Stephen Wozniak (Apple Computer, Inc.), Stephen D. Bechtel, Jr. (Bechtel Group, Inc.), David Packard (Hewlett-Packard Company), Clarence L. Johnson (Lockheed Corporation), Edwin H. Land (Polaroid Corporation) and Edith Flanigen (Union Carbide).